Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HES1 | hg19_v2_chr3_+_193853927_193853944 | -0.22 | 2.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_9189144 Show fit | 2.58 |
ENST00000414642.2
|
G protein-coupled receptor 157 |
|
chr1_-_9189229 Show fit | 1.96 |
ENST00000377411.4
|
G protein-coupled receptor 157 |
|
chr6_+_117586713 Show fit | 1.92 |
ENST00000352536.3
ENST00000326274.5 |
vestigial like 2 (Drosophila) |
|
chr17_+_7348658 Show fit | 1.74 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
|
chr2_-_198650037 Show fit | 1.62 |
ENST00000392296.4
|
boule-like RNA-binding protein |
|
chr3_+_8775466 Show fit | 1.60 |
ENST00000343849.2
ENST00000397368.2 |
caveolin 3 |
|
chrX_-_106960285 Show fit | 1.57 |
ENST00000503515.1
ENST00000372397.2 |
TSC22 domain family, member 3 |
|
chr1_+_41707996 Show fit | 1.49 |
ENST00000425554.1
|
RP11-399E6.1 |
|
chr11_-_47470703 Show fit | 1.40 |
ENST00000298854.2
|
receptor-associated protein of the synapse |
|
chr8_-_141645645 Show fit | 1.40 |
ENST00000519980.1
ENST00000220592.5 |
argonaute RISC catalytic component 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.3 | 3.9 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 3.5 | GO:0033198 | response to ATP(GO:0033198) |
1.1 | 3.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.2 | 3.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 3.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 2.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 2.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 2.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 2.3 | GO:0035329 | hippo signaling(GO:0035329) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 7.7 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 5.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 5.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 4.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 3.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 3.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 3.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 2.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.5 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 3.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 3.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 3.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 2.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 2.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 2.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 2.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.3 | 2.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 2.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 3.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 2.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 2.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 2.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 2.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 2.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 2.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 2.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 2.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |